Wave Life Sciences Taps Shire Finance Exec as CFO
Cambridge, MA-based RNA drug developer Wave Life Sciences (NASDAQ: WVE) has named Keith Regnante its chief financial officer. Regnante was previously the VP of finance at Shire, and had stints at Biogen and Boston Consulting Group before that.
Underwriters and Partners
Xpertise: Watch + Learn
Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX
Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes
Sponsored · Whitepaper
Protecting Valuable Life Science Assets & Equipment: Monitoring Solutions
Remain compliant and ensure optimal productivity
XiltriX